factor VIII inhibitor bypassing activity
PolandMedications containing this active substance
-
Feiba nf
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage Human plasma protein 20-60 mg/1 mL factor VIII inhibitor bypassing activity 50 units/1 mL ATC: B02BD03
Manufacturer: Takeda Manufacturing Austria AG